31.35000 USD
0.65
2.03%
Last update Dec 12, 3:59 PM EST
Market closed
Day range
31.14000
32.30200
Previous close
32
Open
32.16000
Access this stock data via API
Subscribe
TG Therapeutics, Inc.
31.35
0.65
2.03%

Statistics

Valuation metrics
Market cap
4.98B
Enterprise value
4.71B
Trailing P/E (ttm)
11.32
Forward P/E
16.28
PEG ratio
0.00
Price/Sales (ttm)
9.36
Price/Book (mrq)
7.37
Enterprise Value/Revenue
8.85
Enterprise Value/EBITDA
45.77
Overview
Shares outstanding
155.21M
Float
140.39M
Shares short
25.09M
% Held by insiders
6.78%
% Held by institutions
63.81%
Average volume (10 days)
1.44M
Average volume (90 days)
1.97M
Price summary
52-Week low
25.28
52-Week high
46.48
52-Week change
-9.73 -38.5%
Beta
2.01
50-Day moving average
33.09
200-Day moving average
34.95
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
84.13%
Operating margin
18.16%
Operational effectiveness
Return on assets
7.98%
Return on equity
111.96%
Income statement
Revenue (ttm)
531.90M
Revenue per share (ttm)
3.64
Quarterly revenue growth (yoy)
92.80%
Gross profit (ttm)
453.93M
EBITDA
115.24M
Net income to common (ttm)
447.47M
Diluted EPS (ttm)
2.77
Quarterly earnings growth (yoy)
9,974.60%
Balance sheet
Total cash (mrq)
131.58M
Total cash per share (mrq)
0.90
Total debt (mrq)
254.54M
Total Debt/Equity (mrq)
41.92
Current ratio (mrq)
382.50%
Book value per share (mrq)
4.26
Cash flow
Cash flow statement
-70.07M
Levered free cash flow (LFCF)
-94.66M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed (non-working day)
Pre-market opens in 17 hours 11 minutes

10:48
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).